The Daily Biotech Pulse: Liquidia Jumps On New CEO Appointment, Spectrum, Aravive Secure New Funding, Allena To Explore Strategic Alternatives
Here's a roundup of top developments in the biotech space over the last 24 hours:
23 Stocks Moving in Tuesday’s Pre-Market Session
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update.
Allena Stock Is Surging In Premarket Today As It Explores Strategic, Financing Alternatives
Allena Pharmaceuticals Inc (NASDAQ:
Allena’s Stock Surges On FDA Fast Track Tag For Chronic Kidney Disease Candidate
The FDA has granted Fast Track designation to Allena Pharmaceuticals Inc’s (NASDAQ:ALNA) ALLN-346 for hyperuricemia in gout patients with advanced chronic kidney…
22 Stocks Moving in Wednesday’s Pre-Market Session
Gainers
CohBar, Inc. (NASDAQ: CWBR) shares rose 78.3% to $2.30 in pre-market trading after the company reported results from the Phase 1a/1b study of CB4211 under development for NASH and obesity met its primary endpoint. The company also released Q2 results.
Allena Pharmaceuticals Q2 EPS $(0.24) Up From $(0.26) YoY
Allena Pharmaceuticals (NASDAQ:ALNA) reported quarterly losses of $(0.24) per share. This is a 7.69 percent increase over losses of $(0.26) per share from the same period last year.